New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
09:59 EDTSTJ, HPQ, CBSH, FANG, NRGM, HTWR, AMX, EXXI, HRL, EVOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: America Movil (AMX) downgraded to Neutral from Buy at Citigroup... Commerce Bancshares (CBSH) downgraded to Underweight from Equal Weight at Morgan Stanley... Eaton Vance (EV) downgraded to Sell from Neutral at Citigroup... HeartWare (HTWR) downgraded to Market Perform from Outperform at Wells Fargo... Hewlett-Packard (HPQ) downgraded to Sector Perform from Outperform at RBC Capital... Hewlett-Packard (HPQ) downgraded to Underperform from Neutral at Mizuho... Hormel Foods (HRL) downgraded to Underperform from Outperform at CLSA... Inergy Midstream (NRGM) downgraded to Neutral from Outperform at RW Baird... St. Jude Medical (STJ) downgraded to Market Perform from Outperform at Wells Fargo.... Energy XXI (EXXI) initiated with a Buy at Ladenburg... Diamondback Energy (FANG) intiated with an Add at Capital One.
News For AMX;CBSH;EV;HTWR;HPQ;HRL;NRGM;STJ;EXXI;FANG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
February 1, 2016
08:41 EDTFANGDiamondback Energy named top pick at SunTrust
SunTrust says its latest analysis reinforces its view that Diamondback's Midland Basin acreage is among some of the most economic in the industry. The firm says the company has solid management and strong financials. It raised its price target on the name to $95 from 494 and keeps a Buy rating.
January 29, 2016
10:05 EDTFANGOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: American Equity (AEL) initiated with an Outperform at RBC Capital... Calpine (CPN) initiated with a Buy at Guggenheim... Diamondback Energy (FANG) initiated with an Outperform at BMO Capital... Dynegy (DYN) initiated with a Neutral at Guggenheim... ICF International (ICFI) initiated with a Market Perform at Barrington... Juno Therapeutics (JUNO) initiated with a Buy at SunTrust... Kite Pharma (KITE) initiated with a Buy at SunTrust... Match Group (MTCH) initiated with a Neutral at Susquehanna... Medifast (MED) initiated with a Hold at Wunderlich... NRG Energy (NRG) initiated with a Buy at Guggenheim... NRG Yield (NYLD) initiated with a Neutral at Guggenheim... Nutrisystem (NTRI) initiated with a Buy at Wunderlich... Parsley Energy (PE) initiated with an Outperform at BMO Capital... Precision Drilling (PDS) initiated with a Hold at Canaccord... RSP Permian (RSPP) initiated with an Outperform at BMO Capital... Taylor Morrison (TMHC) initiated with a Neutral at Citi... Tortoise North American Energy (TYN) initiated with a Neutral at Guggenheim... WisdomTree (WETF) initiated with a Neutral at Northcoast.
06:14 EDTFANGDiamondback Energy initiated with an Outperform at BMO Capital
Target $74.
January 28, 2016
15:18 EDTHPQXcel Brands collaborates with HP Inc. to create Isaac Mizrahi smartwatch
Subscribe for More Information
13:34 EDTHTWRHeartWare upgraded to Outperform from Market Perform at Wells Fargo
11:11 EDTHTWR, STJHeartWare rallies after scrapping Valtech acquisition
The shares of HeartWare (HTWR) are surging after the company announced that would terminate its acquisition of privately held Valtech. Two research firms reacted positively to the news, with Leerink Swann saying that the company made the right decision, given its current difficulties and Raymond James upgrading HeartWare following the news. HeartWare develops and manufactures miniaturized implantable heart pumps, while Valtech has developed a method of replacing mitral valves in human hearts without the need for open heart surgery. WHAT'S NEW: HeartWare decided to terminate its acquisition of Valtech, the companies announced this morning. Pursuant to the terms of the agreement, HeartWare will make a $30M loan to Valtech in the form of a convertible promissory note. ANALYST REACTION: HeartWare's decision to abandon its acquisition of Valtech was correct in light of the problems that the company is facing with its next generation MVAD pump, Leerink analyst Danielle Antalffy wrote in a note to investors today. Noting that two weeks ago HeartWare announced that it would investigate suction issues that the device has had, the analyst says that fixing the pump could require additional investment, while it's uncertain how long it will take to solve the device's problems. However, the analyst remained upbeat on Heartware's current LVAD products, and believes that it can compete with next generation systems. She kept a $60 price target and Outperform rating on the shares. Raymond James upgraded HeartWare to Outperform from Market Perform, saying that the termination of the Valtech deal removes an overhang on the shares, while the stock's underperformance since September has made its valuation more attractive. Moreover, the stock does not appear to be giving any value to the problematic MVAD pump and the company has a 37% share of a $760M market that has only two main competitors and high barriers to entry, the firm wrote. WHAT'S NOTABLE: In early October 2015, activist investor Engaged Capital urged HeartWare to terminate the Valtech deal. Today HeartWare announced that it would, in conjunction with Engaged Capital, "jointly select" an independent party who will join Heartware's board. ANOTHER TO WATCH: HeartWare's chief rival, Thoratec, was acquired last year by St. Jude Medical (STJ). PRICE ACTION: In late morning trading, HeartWare rose 10% to $37.95. St. Jude, which reported its fourth quarter results and gave fiscal year guidance this morning, is down 1.4% to $53.56.
09:50 EDTHTWRHeartWare upgraded to Outperform from Market Perform at Raymond James
Subscribe for More Information
09:38 EDTHTWRHeartWare likely to trade 'sharply higher' on deal termination, says Leerink
Subscribe for More Information
06:14 EDTHTWRHeartWare announces cooperation agreement with Engaged Capital
Subscribe for More Information
06:13 EDTHTWRHeartWare, Valtech Cardio announce termination of proposed acquisition
Subscribe for More Information
January 27, 2016
08:50 EDTSTJSt. Jude Medical sees FY16 CardioMEMS sales about $65M
Subscribe for More Information
07:31 EDTHRLHormel Foods announces stockholder approval for 2-for-1 stock split
Subscribe for More Information
07:19 EDTSTJSt. Jude Medical sees FY16 sales growth 2%-4%, consensus $6.12B
Subscribe for More Information
07:19 EDTSTJSt. Jude Medical sees Q1 adjusted EPS 87c-98c, consensus 94c
07:18 EDTSTJSt. Jude Medical reports Q4 CRM sales $580M, down 15% y/y
Subscribe for More Information
07:16 EDTSTJSt. Jude Medical reports Q4 adjusted EPS $1.02, consensus $1.01
Reports Q4 revenue $1.47B, consensus $1.47B.
January 26, 2016
14:32 EDTSTJNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Novartis (NVS), consensus $1.18... Boeing (BA), consensus $1.26... United Technologies (UTX), consensus $1.52... Biogen (BIIB), consensus $4.08... EMC (EMC), consensus 65c... General Dynamics (GD), consensus $2.38... Anthem (ANTM), consensus $1.22... Illinois Tool Works (ITW), consensus $1.21... State Street (STT), consensus $1.18... Norfolk Southern (NSC), consensus $1.24... Progressive (PGR), consensus 47c... St. Jude Medical (STJ), consensus $1.01... Rockwell Automation (ROK), consensus $1.33... Textron (TXT), consensus 83c... Hess (HES), consensus ($1.47)... Cliffs Natural (CLF), consensus (26c).
08:19 EDTAMXAmerica Movil upgraded to Overweight from Equal Weight at Morgan Stanley
Subscribe for More Information
07:04 EDTSTJSt. Jude Medical volatility flat into Q4 and outlook
Subscribe for More Information
January 25, 2016
17:16 EDTSTJMMS exploring sale of acute care unit, Reuters says
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use